MB
Marianne Bjordal
Partner at 3B Future Health Ventures
Greater Nice Metropolitan Area
Overview
Marianne Bjordal is a Partner at 3B Future Health Ventures, specializing in life sciences, biotechnology, and venture capital investments, with a focus on stages like Series A and Seed in sectors such as therapeutics and pharmaceuticals. With a background in neuroscience and genetics, Marianne has successfully invested in companies like Sibylla Biotech and Epsilogen, showcasing her expertise in project management and research and development within the pharmaceutical industry.
Work Experience
Partner
2022 - Current
Senior Associate
2019 - 2022
Investment Analyst
2018 - 2019
Board Member
2022
Board member
2022
Board Observer
2022
Board member
2021
Board member
2021
Board Member
2020 - 2021
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
Raised $24,496,508.00 from Innosuisse, Horizon 2020, Eurostars and Innosuisse.
Project Monitor
2018 - 2018
Researcher
2012 - 2017
Neurobiology, genetics, growth, metabolism and development
PhD fellow
2005 - 2011
Marie Curie Early Stage Researcher
PhD fellow
2006 - 2011